Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Prevalence of H1299R polymorphism in the Factor V gene among the Taif-Saudi Arabia population using polymerase chain reaction-reverse hybridization technique.

Awad NS, El-Tarras Ael-S.

Mol Biol Rep. 2012 Jan;39(1):439-43. doi: 10.1007/s11033-011-0756-8. Epub 2011 May 7.

PMID:
21553052
2.

Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese population.

Zaatari GS, Otrock ZK, Sabbagh AS, Mahfouz RA.

Pathology. 2006 Oct;38(5):442-4.

PMID:
17008284
3.

The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.

de Visser MC, Guasch JF, Kamphuisen PW, Vos HL, Rosendaal FR, Bertina RM.

Thromb Haemost. 2000 Apr;83(4):577-82.

PMID:
10780320
4.

Prevalence of the Factor V G1691A and the Factor II/prothrombin G20210A gene polymorphisms among Tamilians.

Angeline T, Bentley HA, Hawk AB, Manners RJ, Mokashi HA, Jeyaraj N, Tsongalis GJ.

Exp Mol Pathol. 2005 Aug;79(1):9-13.

PMID:
15896772
5.

Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.

Otrock ZK, Taher AT, Shamseddeen WA, Zaatari G, Bazarbachi A, Mahfouz RA.

Ann Hematol. 2008 Dec;87(12):1013-6. doi: 10.1007/s00277-008-0543-3. Epub 2008 Jul 25.

PMID:
18654780
6.

Prevalence of the prothrombin G20210A polymorphism in the Lebanese population: use of a reverse hybridization strip assay approach.

Sabbagh AS, Ibrahim G, Kanaan Z, Shammaa DM, Khalek RA, Ghasham M, Greige L, Mahfouz RA.

Mol Biol Rep. 2009 Feb;36(2):399-403. Epub 2007 Dec 8.

PMID:
18066679
7.

The prevalence of methylenetetrahydrofolate reductase 677 C-T, factor V 1691 G-A, and prothrombin 20210 G-A mutations in healthy populations in Setif, Algeria.

Bourouba R, Houcher B, Djabi F, Egin Y, Akar N.

Clin Appl Thromb Hemost. 2009 Oct;15(5):529-34. doi: 10.1177/1076029608319944. Epub 2008 Oct 7.

PMID:
18840629
8.

Spectrum and prevalence of prothrombotic single nucleotide polymorphism profiles in the Greek Cypriot population.

Xenophontos SL, Hadjivassiliou M, Ayrton N, Karagrigoriou A, Pantzaris M, Nicolaides AN, Cariolou MA.

Int Angiol. 2002 Dec;21(4):322-9.

PMID:
12518110
9.

The factor V HR2 haplotype: prevalence and association of the A4070G and A6755G polymorphisms.

Pecheniuk NM, Morris CP, Walsh TP, Marsh NA.

Blood Coagul Fibrinolysis. 2001 Apr;12(3):201-6.

PMID:
11414634
10.

Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.

Akhter MS, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A, Saxena R.

Clin Appl Thromb Hemost. 2010 Apr;16(2):184-8. doi: 10.1177/1076029609333673. Epub 2009 May 5.

PMID:
19419975
11.

Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.

Almawi WY, Keleshian SH, Borgi L, Fawaz NA, Abboud N, Mtiraoui N, Mahjoub T.

J Thromb Thrombolysis. 2005 Dec;20(3):163-8.

PMID:
16261289
12.

Association of BRCA2 variants with cardiovascular disease in Saudi Arabia.

Alanazi M, Reddy NP, Shaik JP, Ajaj SA, Jafari AA, Saeed H, Khan Z, Khan AP.

Genet Mol Res. 2014 May 16;13(2):3876-84. doi: 10.4238/2014.May.16.13.

13.

High prevalence of CYP2D6*41 (G2988A) allele in Saudi Arabians.

Al-Dosari MS, Al-Jenoobi FI, Alkharfy KM, Alghamdi AM, Bagulb KM, Parvez MK, Al-Mohizea AM, Al-Muhsen S, Halwani R.

Environ Toxicol Pharmacol. 2013 Nov;36(3):1063-7. doi: 10.1016/j.etap.2013.09.008. Epub 2013 Sep 21.

PMID:
24121619
14.

The Saudi Thrombosis and Familial Thrombophilia Registry. Design, rational, and preliminary results.

Saour JN, Shoukri MM, Mammo LA.

Saudi Med J. 2009 Oct;30(10):1286-90.

PMID:
19838435
15.

Molecular characterization of factor V leiden G1691A and prothrombin G20210A mutations in Saudi newborns with stroke.

Gawish GE.

Biochem Genet. 2011 Oct;49(9-10):601-10. doi: 10.1007/s10528-011-9435-7. Epub 2011 Apr 2.

PMID:
21461667
16.

Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.

Kostka H, Schwarz T, Schellong S, Mix C, Kuhlisch E, Temelkova-Kurktschiev T, Henkel E, Köhler C, Gehrisch S, Siegert G.

Blood Coagul Fibrinolysis. 2003 Jan;14(1):49-56.

PMID:
12544728
17.

Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.

Rahimi Z, Vaisi-Raygani A, Mozafari H, Kharrazi H, Rezaei M, Nagel RL.

J Thromb Thrombolysis. 2008 Jun;25(3):280-3. Epub 2007 Aug 14.

PMID:
17700999
18.

Association of the R485K polymorphism of the factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese population.

Le W, Yu JD, Lu L, Tao R, You B, Cai X, Cao WJ, Huang W, He RM, Zhu DL, Chen Z, Gong LS.

Clin Genet. 2000 Apr;57(4):296-303.

PMID:
10845571
19.

HLA DQ alpha genotype and allele frequencies in Qatari population.

Sebetan IM, Hajar HA.

Forensic Sci Int. 1997 Nov 10;90(1-2):11-5.

PMID:
9438361
20.

Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.

Rahimi Z, Ghaderi M, Nagel RL, Muniz A.

J Thromb Thrombolysis. 2008 Dec;26(3):229-33. Epub 2007 Nov 4.

PMID:
17982733
Items per page

Supplemental Content

Write to the Help Desk